Exclusive Sage, senior living operating system, raises 35 million Series B led by IVP
SAGE Stock | USD 5.54 0.19 3.32% |
About 55% of Sage Therapeutic's shareholders are presently thinking to get in. The analysis of the overall investor sentiment regarding Sage Therapeutic suggests that some traders are interested. The current market sentiment, together with Sage Therapeutic's historical and current headlines, can help investors time the market. In addition, many technical investors use Sage Therapeutic stock news signals to limit their universe of possible portfolio assets.
Sage |
Sage has raised a 35 million Series B, led by IVP, Fortune can exclusively report.
Read at finance.yahoo.com
Sage Therapeutic Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Sage Therapeutic can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Sage Therapeutic Fundamental Analysis
We analyze Sage Therapeutic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sage Therapeutic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sage Therapeutic based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Per Share
Cash Per Share Comparative Analysis
Sage Therapeutic is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Sage Therapeutic Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sage Therapeutic stock to make a market-neutral strategy. Peer analysis of Sage Therapeutic could also be used in its relative valuation, which is a method of valuing Sage Therapeutic by comparing valuation metrics with similar companies.
Peers
Sage Therapeutic Related Equities
VTYX | Ventyx Biosciences | 2.15 | ||||
DMAC | DiaMedica Therapeutics | 1.31 | ||||
DAWN | Day One | 0.23 | ||||
MDGL | Madrigal Pharmaceuticals | 0.30 | ||||
ARVN | Arvinas | 0.42 | ||||
INCY | Incyte | 0.47 | ||||
KRYS | Krystal Biotech | 0.75 | ||||
APLS | Apellis Pharmaceuticals | 0.85 | ||||
STOK | Stoke Therapeutics | 1.60 | ||||
TERN | Terns Pharmaceuticals | 1.87 | ||||
ALNY | Alnylam Pharmaceuticals | 1.87 | ||||
RLAY | Relay Therapeutics | 2.02 | ||||
NUVL | Nuvalent | 2.14 | ||||
AKRO | Akero Therapeutics | 2.22 | ||||
BPMC | Blueprint Medicines | 2.42 | ||||
PLRX | Pliant Therapeutics | 3.35 | ||||
IMCR | Immunocore Holdings | 3.44 | ||||
BDTX | Black Diamond | 4.78 | ||||
AMLX | Amylyx Pharmaceuticals | 4.91 |
Complementary Tools for Sage Stock analysis
When running Sage Therapeutic's price analysis, check to measure Sage Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sage Therapeutic is operating at the current time. Most of Sage Therapeutic's value examination focuses on studying past and present price action to predict the probability of Sage Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sage Therapeutic's price. Additionally, you may evaluate how the addition of Sage Therapeutic to your portfolios can decrease your overall portfolio volatility.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Stocks Directory Find actively traded stocks across global markets |